Tirzepatide has more dose steps than most treatments people encounter, and the sheer number of them is the main source of confusion. Six strengths, a minimum of four weeks at each, and several legitimate places to stop along the way. The good news is that the structure is logical once you see it whole, and that the schedule is a framework rather than a timetable you have to keep up with. This is the full picture, and what actually determines where you end up.
The full schedule
Treatment starts at 2.5 mg once weekly for four weeks. It then moves to 5 mg weekly, and after at least a further four weeks may increase in 2.5 mg steps: 7.5 mg, then 10 mg, then 12.5 mg, then 15 mg, which is the maximum. Every injection is weekly, ideally on the same day, and the day can be moved if needed as long as at least three days separate two injections. Reaching 15 mg from the start therefore takes a minimum of twenty weeks, and in practice commonly longer.
The difference between a step and a destination
This is the part most charts omit, and it matters more than the numbers. The 2.5 mg dose is purely a tolerance-building step: it is not expected to deliver meaningful weight loss and nobody stays on it. But 5 mg, 10 mg and 15 mg are all recognised maintenance doses, meaning treatment can legitimately settle at any of them. The 7.5 mg and 12.5 mg strengths exist mainly as intermediate steps for people who need a gentler climb. So the chart is not a ladder you must climb to the top; it is a route with three proper stopping points, and which one you reach depends on how your appetite and weight respond rather than on completing the set.
Why four weeks, and why often longer
Four weeks is a minimum interval rather than a target, chosen because it is roughly how long the digestive system needs to adapt to a new amount of drug. Increasing sooner reliably produces nausea and vomiting without producing faster results. Staying longer is a normal clinical decision, and there are two good reasons for it: side effects that have not yet settled, and steady weight loss that does not need more medicine. Someone losing weight comfortably at 7.5 mg has no reason to move to 10 mg simply because four weeks have passed. The dose exists to control appetite, and once it is doing that, more is not better.
Going down as well as up
The chart is usually drawn as a one-way climb, which is misleading. If a dose proves difficult, dropping back to the previous one is a legitimate option and often the right one, either as a temporary retreat before trying the increase again more slowly, or as a settled maintenance decision. People sometimes resist this because it feels like going backwards, but a dose you tolerate and take reliably will always outperform a higher dose you skip, dread or abandon. The same logic applies after a break in treatment: if more than a couple of weeks pass without an injection, your prescriber may want to restart lower and rebuild, because tolerance fades faster than most people expect. Missing a single dose is handled differently: if the next scheduled injection is more than three days away, take the missed one when you remember, and otherwise skip it and resume as normal without doubling up.
Reading your own progress
Two signals decide whether the next step is needed. The first is appetite: if you are genuinely less hungry, eating smaller portions without a constant fight, the current dose is working. The second is the trend on the scale over several weeks rather than day to day, since weight moves for many reasons and a single reading tells you almost nothing. When appetite control has clearly faded and weight loss has flattened for a month at a dose you tolerate well, that is the case for an increase. When appetite is controlled and progress is steady, there is no case at all. It is worth separating a genuine plateau from an apparent one, because weight commonly stalls for two or three weeks and then moves again without anything changing, and increasing the dose during one of those pauses attributes the later drop to the new dose rather than to ordinary variation. Waiting for four weeks of flat readings before concluding anything avoids climbing the chart faster than the evidence justifies.
Using the chart well
The most useful way to hold all this is to stop thinking of the schedule as a plan with a finishing line and start treating it as a series of decisions, each taken with a month of evidence behind it. Look at the calendar before an increase rather than after, because unsettled days arrive in the week following a step up and stepping up before a holiday or a demanding week is trouble a fortnight's delay would have avoided. Keep brief notes through each transition, what you felt, how long it lasted and what helped, since your own pattern tends to repeat and turns the next increase from an unknown into logistics. Bring those notes to reviews, because a prescriber shown a clear record can tell a normal adjustment from something needing attention far faster than one working from a vague impression that the last month was hard. A chart followed thoughtfully and a chart followed mechanically produce quite different experiences of the same medicine.
